THE MOLECULAR CROSS-TALK AMONG ARG/ABL2, TGF-b1 AND LOX IN CLEAR CELL RENAL CELL CARCINOMA PROGRESSION


Article ID: 6481
Vol 32, Issue 4S1, 2018
DOI: https://doi.org/10.54517/jbrha6481
Received: 8 September 2018; Accepted: 8 September 2018; Available online: 8 September 2018; Issue release: 8 September 2018

Abstract

An involvement of TGF-b1 in promoting bone metastases affecting about 30% of clear cell Renal CellCarcinoma (ccRCC) patients was described. The extracellular matrix enzyme Lysyl oxidase (Lox) throughosteoclast activation and osteoblast inhibition induces pre-metastatic bone lesions in breast and coloncancer. We evidenced Lox overexpression in ccRCC and TGF-b1 production modulated by Arg tyrosinekinase in renal tubular cells. Arg modulates invasion and metastasis of breast and prostate cancer throughcytoskeleton regulation. These data suggest that Arg, TGF-b1 and Lox might interact to promote tumorinvasion and metastasis. Here we analyse the molecular and functional interactions among Arg, TGF-b1and Lox in ccRCC and their effects on osteoclast and osteoblast pre-metastatic functions.



References

Supporting Agencies



Copyright (c) 2018




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).